Lv1
40 积分 2025-08-20 加入
CADD-engineered peptide protacs efficiently target PCSK9 for hypercholesterolemia in vivo
3个月前
已完结
Clinical efficacy and safety of achieving very low LDL-cholesterol concentrations with the PCSK9 inhibitor evolocumab: a prespecified secondary analysis of the FOURIER trial
3个月前
已完结
Efficacy and safety of ongericimab given by prefilled syringe or autoinjector in primary hypercholesterolemia and mixed hyperlipidemia
3个月前
已完结
Effects of Heavy Alcohol Use on Acute Intracerebral Hemorrhage and Cerebral Small Vessel Disease
5个月前
已完结
Sleep duration and timing are associated with next-day physical activity: Insights from two large-scale wearable sensor studies
7个月前
已完结
皖公网安备34019202002308
